CCND1 AMPLIFICATION AND PROTEIN OVEREXPRESSION IN ORAL SQUAMOUS CELL CARCINOMA OF YOUNG PATIENTS

被引:35
|
作者
Kaminagakura, Estela [1 ]
da Cunha, Isabela Werneck [2 ]
Soares, Fernando Augusto [2 ]
Nishimoto, Ines Nobuko [1 ]
Kowalski, Luiz Paulo [1 ]
机构
[1] AC Camargo Hosp, Dept Head & Neck Surg & Otorhinolaryngol, Sao Paulo, Brazil
[2] AC Camargo Hosp, Dept Anat Pathol, Sao Paulo, Brazil
基金
巴西圣保罗研究基金会;
关键词
oral cancer; young patient; oral squamous cell carcinoma; tissue microarray; fluorescence in situ hybridization (FISH); CYCLIN D1 OVEREXPRESSION; PROGNOSTIC-SIGNIFICANCE; VERRUCOUS CARCINOMA; GENE AMPLIFICATION; RISK-FACTORS; EXPRESSION; TONGUE; HEAD; NECK; CANCER;
D O I
10.1002/hed.21618
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Background. The purpose of this study was to evaluate the correlation of CCND1 amplification and protein overexpression with clinicopathological features and clinical outcomes in patients younger than 41 years old with oral squamous cell carcinoma (SCC). Methods. Eighty-six young patients with oral SCC were evaluated using the tissue microarray technique, immunohistochemistry, and fluorescence in situ hybridization (FISH). These cases were compared with 116 patients with oral cancer aged over 50 years old (controls). Results. Cyclin D1 overexpression was observed in 47.7% of tumors in the young group and in 32.8% of controls (p = .03). In the young group, CCND1 amplification and overexpression were higher than in the control patients and the differences were statistically significant. In the young group, protein overexpression correlated with diminished disease-free survival (DFS), whereas in the control patients, cyclin D1 overexpression correlated with diminished DFS and overall survival (OS). Conclusion. In both groups, amplification had no influence on prognosis. Protein overexpression was an indicator of worse DFS in both groups. (C) 2011 Wiley Periodicals, Inc. Head Neck 33: 1413-1419, 2011
引用
收藏
页码:1413 / 1419
页数:7
相关论文
共 50 条
  • [21] Association of CDK4 and CCND1 mRNA overexpression in laryngeal squamous cell carcinomas occurs without CDK4 amplification
    Nadal, Alfons
    Jares, Pedro
    Pinyol, Magda
    Conde, Laura
    Romeu, Coia
    Fernandez, Pedro L.
    Campo, Elias
    Cardesa, Antonio
    VIRCHOWS ARCHIV, 2007, 450 (02) : 161 - 167
  • [22] CCND1 amplification and cyclin D1 immunohistochemical expression in head and neck squamous cell carcinomas
    Henning Hanken
    Alexander Gröbe
    Georg Cachovan
    Ralf Smeets
    Ronald Simon
    Guido Sauter
    Max Heiland
    Marco Blessmann
    Clinical Oral Investigations, 2014, 18 : 269 - 276
  • [23] CCND1 as a Predictive Biomarker of Neoadjuvant Chemotherapy in Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma
    Feng, Zhien
    Guo, Wei
    Zhang, Chenping
    Xu, Qin
    Zhang, Ping
    Sun, Jian
    Zhu, Hanguang
    Wang, Zhonghe
    Li, Jiang
    Wang, Lizhen
    Wang, Bingshun
    Ren, Guoxin
    Ji, Tong
    Tu, Wenyong
    Yang, Xihu
    Qiu, Weiliu
    Mao, Li
    Zhang, Zhiyuan
    Chen, Wantao
    PLOS ONE, 2011, 6 (10):
  • [24] Association of CDK4 and CCND1 mRNA overexpression in laryngeal squamous cell carcinomas occurs without CDK4 amplification
    Alfons Nadal
    Pedro Jares
    Magda Pinyol
    Laura Conde
    Coia Romeu
    Pedro L. Fernández
    Elías Campo
    Antonio Cardesa
    Virchows Archiv, 2007, 450 : 161 - 167
  • [25] CCND1 amplification and cyclin D1 immunohistochemical expression in head and neck squamous cell carcinomas
    Hanken, Henning
    Groebe, Alexander
    Cachovan, Georg
    Smeets, Ralf
    Simon, Ronald
    Sauter, Guido
    Heiland, Max
    Blessmann, Marco
    CLINICAL ORAL INVESTIGATIONS, 2014, 18 (01) : 269 - 276
  • [26] Association between cyclin D1 (CCND1) gene amplification and human papillomavirus infection in human laryngeal squamous cell carcinoma
    Cattani, P
    Hohaus, S
    Bellacosa, A
    Genuardi, M
    Cavallo, S
    Rovella, V
    Almadori, G
    Cadoni, G
    Galli, J
    Maurizi, M
    Fadda, G
    Neri, G
    CLINICAL CANCER RESEARCH, 1998, 4 (11) : 2585 - 2589
  • [27] Genetic polymorphisms of CCND1 and PTEN in progression of esophageal squamous carcinoma
    Jang, Y.
    Lu, S. A.
    Chen, Z. P.
    Ma, J.
    Xu, C. Q.
    Zhang, C. Z.
    Wang, J. J.
    GENETICS AND MOLECULAR RESEARCH, 2013, 12 (04) : 6685 - 6691
  • [28] Cyclin D1 gene (CCND1) polymorphism and the risk of squamous cell carcinoma of the larynx
    Rydzanicz, M
    Golusinski, P
    Mielcarek-Kuchta, D
    Golusinski, W
    Szyfter, K
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2006, 263 (01) : 43 - 48
  • [29] Cyclin D1 gene (CCND1) polymorphism and the risk of squamous cell carcinoma of the larynx
    Malgorzata Rydzanicz
    Pawel Golusinski
    Daniela Mielcarek-Kuchta
    Wojciech Golusinski
    Krzysztof Szyfter
    European Archives of Oto-Rhino-Laryngology and Head & Neck, 2006, 263 : 43 - 48
  • [30] TP53 GENE-MUTATIONS AND CCND1 GENE AMPLIFICATION IN HEAD AND NECK SQUAMOUS-CELL CARCINOMA CELL-LINES
    XU, L
    DAVIDSON, BJ
    MURTY, VVVS
    LI, RG
    SACKS, PG
    GARINCHESA, P
    SCHANTZ, SP
    CHAGANTI, RSK
    INTERNATIONAL JOURNAL OF CANCER, 1994, 59 (03) : 383 - 387